Digital holographic microscopy as multimodal read out for in vitro nanomaterial cytotoxicity testing

Digital holographic microscopy (DHM) was used as multimodal optical method for nanomaterial toxicity testing that overcomes the limitations and assay disturbances of conventional in vitro assays based on absorbance or fluorescence read outs.

[1]  Alexandra Kroll,et al.  Interference of engineered nanoparticles with in vitro toxicity assays , 2012, Archives of Toxicology.

[2]  Daniel Carl,et al.  Modular digital holographic microscopy system for marker free quantitative phase contrast imaging of living cells , 2006, SPIE Photonics Europe.

[3]  Lang Tran,et al.  Comprehensive In Vitro Toxicity Testing of a Panel of Representative Oxide Nanomaterials: First Steps towards an Intelligent Testing Strategy , 2015, PloS one.

[4]  Patrik Langehanenberg,et al.  Integral refractive index determination of living suspension cells by multifocus digital holographic phase contrast microscopy. , 2007, Journal of biomedical optics.

[5]  Alexandra Kroll,et al.  Current in vitro methods in nanoparticle risk assessment: limitations and challenges. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[6]  Sarah Mues,et al.  Novel optical approaches for label-free quantification of nano-cytotoxic effects , 2016, SPIE BiOS.

[7]  Robert Nadon,et al.  Statistical practice in high-throughput screening data analysis , 2006, Nature Biotechnology.

[8]  Steffi Ketelhut,et al.  Multimodal label-free in vitro toxicity testing with digital holographic microscopy , 2014, Photonics Europe.

[9]  Björn Kemper,et al.  Virulence from vesicles: Novel mechanisms of host cell injury by Escherichia coli O104:H4 outbreak strain , 2015, Scientific Reports.

[10]  D. Dirksen,et al.  Autofocusing in digital holographic phase contrast microscopy on pure phase objects for live cell imaging. , 2008, Applied optics.

[11]  Jérôme Parent,et al.  Label-free cytotoxicity screening assay by digital holographic microscopy. , 2013, Assay and drug development technologies.

[12]  Steffi Ketelhut,et al.  Simplified setup for imaging with digital holographic microscopy and enhanced quantitative phase contrast by osmotic stimulation of living cells , 2011, BiOS.

[13]  Alexandra Kroll,et al.  Cytotoxicity screening of 23 engineered nanomaterials using a test matrix of ten cell lines and three different assays , 2011, Particle and Fibre Toxicology.

[14]  Steffi Ketelhut,et al.  Quantitative Stain-Free and Continuous Multimodal Monitoring of Wound Healing In Vitro with Digital Holographic Microscopy , 2014, PloS one.

[15]  Björn Kemper,et al.  Manipulating intracellular refractive index for contrast-enhanced digital holographic imaging of subcellular structures , 2011, BiOS.

[16]  Sarah Mues,et al.  Optical analysis of nanomaterial-cell interactions: flow cytometry and digital holographic microscopy , 2015, Optical Metrology.

[17]  Steffi Ketelhut,et al.  Multimodal label-free growth and morphology characterization of different cell types in a single culture with quantitative digital holographic phase microscopy , 2015, Photonics West - Biomedical Optics.

[18]  Daniel Carl,et al.  Investigation of living pancreas tumor cells by digital holographic microscopy. , 2006, Journal of biomedical optics.

[19]  Steffi Ketelhut,et al.  Continuous morphology and growth monitoring of different cell types in a single culture using quantitative phase microscopy , 2015, Optical Metrology.

[20]  Christian Depeursinge,et al.  Noninvasive characterization of the fission yeast cell cycle by monitoring dry mass with digital holographic microscopy. , 2009, Journal of biomedical optics.